CSR Study : Crunch could reduce corporate social responsibility

In a poll by Echo Research , 36 per cent of senior professionals said they believed the number of corporate social responsibility programmes would fall ...

Novartis Study

Omnibus Survey, Echo Research, April-May 2008. [2] Ezzati et al. Selected major risk factors and global regional burden of disease. The Lancet. ...

Jolly Good Fellows with a Purpose

by David Michaelson, Echo Research.
 

Organizations concerned with healthcare and pharmaceuticals globally have an intense need for information to assess how they are perceived and what their stakeholders want. They question how issues ranging from drug access to pricing and effectiveness can turn into crises and how best to manage the communication of their messages to their publics.

From its very beginning, Echo Research has effectively and impartially provided such assessments to clients who are the leaders of the healthcare sector -- government health agencies, developers and manufacturers of pharmaceutical products, healthcare providers. Clients have used Echo to provide:

  • Risk assessment and issues management
  • Stakeholder mapping
  • Brand surveys among employees and families
  • Pre-testing of communication strategy
  • Readership surveys
  • Management development surveys
  • Drug launch evaluation
  • Communications effectiveness audits and key performance indicators

Echo customizes research programs to tap the attitudes of a large array of stakeholders in this sector, including elected officials and government departments; healthcare providers and patient groups; scientists, universities and research centers; media, voluntary and non-government organizations; opinion formers, and, not least, the general public.

For a review of how Echo Research can meet your information needs, Contact Us

 
Copyright 2006 Echo Research
 
 

Healthcare & Pharmaceuticals